Cargando…

Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance

The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Holmes, Emily A. F., Hughes, Dyfrig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963561/
https://www.ncbi.nlm.nih.gov/pubmed/31569624
http://dx.doi.org/10.3390/antibiotics8040166
_version_ 1783488308442038272
author Holmes, Emily A. F.
Hughes, Dyfrig A.
author_facet Holmes, Emily A. F.
Hughes, Dyfrig A.
author_sort Holmes, Emily A. F.
collection PubMed
description The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation.
format Online
Article
Text
id pubmed-6963561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69635612020-01-30 Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance Holmes, Emily A. F. Hughes, Dyfrig A. Antibiotics (Basel) Commentary The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation. MDPI 2019-09-27 /pmc/articles/PMC6963561/ /pubmed/31569624 http://dx.doi.org/10.3390/antibiotics8040166 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Holmes, Emily A. F.
Hughes, Dyfrig A.
Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title_full Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title_fullStr Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title_full_unstemmed Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title_short Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
title_sort challenges for economic evaluation of health care strategies to contain antimicrobial resistance
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963561/
https://www.ncbi.nlm.nih.gov/pubmed/31569624
http://dx.doi.org/10.3390/antibiotics8040166
work_keys_str_mv AT holmesemilyaf challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance
AT hughesdyfriga challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance